Previous cancer of spouse as a predictor for mortality after personal diagnosis of cancer.

Authors

null

Tamar Peretz

Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

Tamar Peretz , Lea Baider , Gil Goldzweig , Jeremy M Jacobs , Aviad Zick , Yakir Rottenberg

Organizations

Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel, Hebrew University Medical School, Hadassah University Hospital, Jerusalem, Israel, Academic College of Tel Aviv Yaffo, Tel Aviv, Israel, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Research Funding

No funding sources reported

Background: Previous experience may affect further coping with illness. The aim of the current study was to evaluate the association between prior cancer of spouse with mortality following a personal diagnosis of cancer. Methods: A historical prospective study, with cohort inception and baseline measurement of people participating in the Central Bureau of Statistics 1995 census, was designed. Cancer incidence was ascertained through the Israel Cancer Registry and followed up until 2011. Multivariate Cox proportional hazards models were used to assess hazard ratios for mortality among study subjects following cancer of their spouse, while controlling for age, sex, marital status and ethnicity. In order to exclude lead time bias and smoking effect, further analyses which restricted to stage IV cancers and models which excluded smoking associated cancers (lung, head and neck, renal, and bladder cancers) were carried. Results: A total of 133,550 cases of cancer and 61,048 deaths were reported during the study period. The effect on mortality was mediated by spouse’s survival at the time of self-diagnosis; mortality of spouse, at the time of personal diagnosis of cancer was associated with increased risk for death (HR=1.07, 95%CI: 1.02-1.12) compared with reduced risk of personal mortality following a diagnosis of cancer in spouse whose was alive at time of diagnosis (HR=0.90, 95%CI: 0.87-0.94). The gender effect was more prominent in stage IV patients; only males were susceptible to the negative effect after spouse mortality (HR=1.20, 95%CI: 1.06-1.36) while the protective effect of a spouse who was alive at time of self-diagnosis was significant only among females (HR=0.79, 95%CI: 0.71-0.89). These results were similar in the models which included only non-smoking associated cancers. Conclusions: Mortality followed cancer diagnosis is affected by prior diagnosis of cancer among the spouse. This effect is influenced by the survival of the spouse at the time of cancer diagnosis and gender.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Psychosocial and Communication Research

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 9564)

DOI

10.1200/jco.2014.32.15_suppl.9564

Abstract #

9564

Poster Bd #

214

Abstract Disclosures

Similar Abstracts

First Author: Shaniza Haniff

First Author: Ali Shamseddine

Abstract

2017 Genitourinary Cancers Symposium

Discerning predictors for gender differences in survival outcomes for patients treated for bladder cancer.

First Author: Preston Kerr